Fortunato Ron Rocca
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-01-22–present
-
Current
-
Interpace Biosciences, Inc. (IDXG)
Proxy statement
Current -
Start not stated–2022-10-16
-
Start not stated–2022-10-16
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Exagen Inc. (XGN) | former President and Chief Executive Officer | $447,218 | $1,542,043 |
| 2021 | Exagen Inc. (XGN) | former President and Chief Executive Officer | $594,707 | $2,439,628 |
| 2020 | Exagen Inc. (XGN) | President and Chief Executive Officer | $499,733 | $2,817,685 |
| 2019 | Exagen Inc. (XGN) | President and Chief Executive Officer | $358,195 | $1,627,725 |
| 2018 | Exagen Inc. (XGN) | President and Chief Executive Officer | $348,113 | $567,219 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.